The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

13 articles for MJ Ryan


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Structure-activity relationships of a series of 2-amino-4-thiazole-containing renin inhibitors.EBI
Parke-Davis Pharmaceutical Research Division of Warner-Lambert
Design and synthesis of potent, selective, and orally active fluorine-containing renin inhibitors.EBI
Warner-Lambert
N6-substituted adenosine receptor agonists: potential antihypertensive agents.EBI
Warner-Lambert
Synthesis and angiotensin-converting enzyme inhibitory activity of 3-(Mercaptomethyl)-2-oxo-1-pyrrolidineacetic acids and 3-(Mercaptomethyl)-2-oxo-1-piperidineacetic acids.EBI
TBA
 
Tetrahydroisoquinoline as a phenylalanine replacement in renin inhibitorsEBI
TBA
Benzyl ether structure-activity relationships in a series of ketopiperazine-based renin inhibitors.EBI
Pfizer
Equipotent activity in both enantiomers of a series of ketopiperazine-based renin inhibitors.EBI
Pfizer
Structure-activity relationships for a novel series of pyrido[2,3-d]pyrimidine tyrosine kinase inhibitors.EBI
Parke-Davis Pharmaceutical Research
Mammalian and bacterial nitric oxide synthase inhibitorsBDB
Northwestern University
Lactams as inhibitors of rockBDB
Bristol-Myers Squibb
Inhibitors of SYKBDB
Hoffmann-La Roche
Amino pyridine derivatives as phosphatidylinositol 3-kinase inhibitorsBDB
Novartis
Substituted cyanoguanidines as oral anti-viralsBDB
Abbvie